Recent news on Levulan

DUSA Pharmaceuticals to Present at the Friedman, Billings, Ramsey ...  -  25 May 2007
Genetic Engineering News (press release),DUSA Pharmaceuticals, Inc. is an integrated dermatology pharmaceutical company focused primarily on the development and marketing of its Levulan(R)

DUSA's Orphan Isn't Unique  -  May 21, 2007
Motley FoolShares of DUSA Pharmaceuticals (Nasdaq: DUSA) were up 72% last Thursday after the company announced that its lead drug candidate, Levulan, received orphan

Thursday's Small-Cap Winners & Losers  -  May 17, 2007
TheStreet.com...lately rocketing 57% in extremely heavy trading after the Food and Drug Administration granted "orphan drug" status to Levulan, the Wilmington, Mass.,

On The Move For Thursday, May 17  -  May 17, 2007
Forbes,Dusa makes a dermatology drug called Levulan that treats damage to the esophagus. The Food and Drug Administration granted "orphan" status to the

DUSA Pharmaceuticals Soars To Multi-Month High  -  May 17, 2007
Trading Markets,Thursday morning, the company announced that FDA granted an Orphan Drug Designation for its Levulan Photodynamic Therapy or PDT for the treatment of

Biosite plans to accept Inverness buyout offer  -  Apr 27, 2007
Boston Globe,The ad for the topical solution Levulan Kerastick "raises significant public health and safety concerns" because it says the product is safer and works

Caught in the middle  -  Mar 29, 2007
Tulsa World,High-tech: Masters and other medical professionals say they're impressed by results from new treatment methods using Levulan (amniolevulanic acid) and

DUSA Pharmaceuticals Reports Fourth-Quarter and Year-End 2006 ...  -  Mar 16, 2007
PharmaLive.com (press release),The revenue increases were mainly reflective of significant Levulan Kerastick(R) unit volume sales growth, as well as the addition of non-PDT revenue

DUSA Pharmaceuticals, Inc. to Host Fourth Quarter and Full Year ...  -  Mar 13, 2007
SYS-CON Media,DUSA Pharmaceuticals, Inc. is an integrated dermatology specialty pharmaceutical company focused primarily on the development and marketing of its Levulan®

DUSA Pharmaceuticals, Inc. to Host Fourth Quarter and Full Year ...  -  Mar 13, 2007
Genetic Engineering News (press release),Levulan PDT is currently approved for the treatment of pre-cancerous actinic keratoses, and is being developed for the treatment of acne.

Dusa Pharmaceuticals 4Q Loss Widens  -  Mar 16, 2007
Houston Chronicle,The company said the sales increase was due to Levulan Kerastick unit volume sales growth and additional revenue from products received in its Sirius

DUSA Pharma Posts Wider GAAP Net Loss In Q4 - Update  -  Mar 16, 2007
Trading Markets,The company attributed the revenue increase to significant Levulan Kerastick unit volume sales growth and addition of non-PDT revenue associated with

A Global Review at the American Academy of Dermatology Annual ...  -  Feb 7, 2007
PharmaLive.com (press release),..."Levulan PDT is emerging as an important AK treatment modality and is being studied by DUSA for the treatment of acne, as well as by independent

Life goes on, thanks to science  -  Feb 14, 2007
The Vail Trail,The back will then be exposed to blue light in a procedure as the Levulan PDT System that will kill Actinic Keratoses, the earliest skin cancer.

Where to get your Gidget fix  -  Jan 27, 2007
Toronto Star,Levulan + IPL is another option, she says. A topical FDA-approved medication, Levulan treats unevenness in skin and clears up acne, bacteria and brown spots

Cutera Announces Physician Luminaries on Podium at Annual Meeting ...  -  Feb 1, 2007
Earthtimes.orgAmy Taub, MD, will discuss results of a study demonstrating that Cutera's Intense-Pulsed Light (IPL) is superior for activating Levulan in the treatment of

International Photo-Dynamic Therapy Guidelines Launched for the ...  -  18 Jan 2007
DG NewsLevulan®, Kerastick® and BLU-U® are registered trademarks of DUSA Pharmaceuticals Inc for the US market. The new guidelines outline the criteria and

DUSA Pharmaceuticals Announces Exclusive Agreeme nt with Daewoong ...  -  Jan 8, 2007
PharmaLive.com (press release),The agreement covers current and future uses of DUSA's proprietary Levulan(R) Kerastick(R) for photodynamic therapy (PDT) in dermatology.

Market Report -- In Play (DUSA)  -  Jan 8, 2007
MSN MoneyDUSA Pharma announces exclusive agreement with Daewoong to mkt DUSA's Levulan'R' Kerastick'R' for photodynamic therapy in Asian territories Co announces

This Week's Business News and Notes  -  Jan 10, 2007
Falls Church News Press,...combination of Alpha & Beta Hydroxyacid peels, or the “Extreme Skin Rejuvenation� with VibraDermabrasion, acid peels, and laser treatment with Levulan®.

DUSA Pharmaceuticals, Inc. Clarifies USPTO Action and River's Edge ...  -  Dec 8, 2006
PharmaLive.com (press release),Levulan PDT is currently approved for the treatment of pre-cancerous actinic keratoses, and is being developed for the treatment of acne and photodamage.

DUSA Pharmaceuticals, Inc. Clarifies USPTO Action and River's Edge ...  -  Dec 8, 2006
CCNMatthews (press release),DUSA Pharmaceuticals, Inc. is an integrated dermatology specialty pharmaceutical company focused primarily on the development and marketing of its Levulan

Dusa Pharmaceuticals Reports Brazilian Regulatory Approval for ...  Oct 17, 2006
...marketing partner for Latin America, has been informed by ANVISA, the Brazilian drug regulatory authorities, that the Levulan® Kerastick® (aminolevulinic ... -DG News DUSA Pharmaceuticals Reports Brazilian Regulatory Approval for ...  Oct 17, 2006
Inc., DUSA's marketing partner for Latin America, has been informed by ANVISA, the Brazilian drug regulatory authorities, that the Levulan(R) Kerastick(R) has ... -Genetic Engineering News (press release), DUSA Pharmaceuticals Reports Third Quarter 2006 Corporate ...  Nov 3, 2006
DUSA Pharmaceuticals, Inc. (NASDAQ GM: DUSA), a dermatology company that is developing and marketing Levulan photodynamic therapy ("PDT") and other treatments ... -Genetic Engineering News (press release), DUSA Pharmaceuticals Reports Third Quarter 2006 Corporate ...  Nov 3, 2006
...(NASDAQ GM: DUSA), a dermatology company that is developing and marketing Levulan photodynamic therapy ("PDT") and other treatments for common skin conditions ... -Market Wire (press release) DUSA Pharmaceuticals to Present at CIBC World Markets 17th Annual ...  Nov 1, 2006
...is an integrated dermatology specialty pharmaceutical company focused primarily on the development and marketing of its Levulan® Photodynamic Therapy (PDT ... -Market Wire (press release) Basics of nonsurgical face-lifts  Oct 29, 2006
...skin. A photosensitizing agent applied to the skin, such as Levulan or Kerastick, can make the treatment even more effective. Chrystal ... -Los Angeles Daily News, Market Report -- In Play (DUSA)  Oct 17, 2006
DUSA Pharma reports Brazilian regulatory approval for Levulan Co reported that Stiefel Laboratories DUSA's marketing partner for Latin America, has been ... -MSN Money Dusa acne solution is approved in Brazil  Oct 17, 2006
Wilmington, Mass.-headquartered Dusa (Nasdaq: DUSA) said the approval is for Levulan Kerastick, a solution to prime the skin, making affected areas more ... -Bizjournals.com, Dusa gets Brazilian OK for acne solution  Oct 17, 2006
...regulatory approvals. Levulan Kerastick is a solution to prime the skin, making affected areas more sensitive to light treatment. (AP). -Boston Globe, DUSA Pharmaceuticals, Inc. Clarifies USPTO Action and River's Edge ...  -  12 Dec 2006
PharmaLive.com (press release),Levulan PDT is currently approved for the treatment of pre-cancerous actinic keratoses, and is being developed for the treatment of acne and photodamage.

DUSA Pharmaceuticals, Inc. Clarifies USPTO Action and River's Edge ...  -  12 Dec 2006
CCNMatthews (press release),DUSA Pharmaceuticals, Inc. is an integrated dermatology specialty pharmaceutical company focused primarily on the development and marketing of its Levulan

DUSA Pharmaceuticals Reports Second Quarter 2006 Corporate ...  Aug 8, 2006
Stiefel Laboratories, Inc., the Company's Latin American partner, is actively working towards a Brazilian launch of Levulan®, scheduled for the first quarter ... -Market Wire

DUSA Pharmaceuticals, Inc. to Host Second Quarter Corporate ...  Aug 3, 2006
...is an integrated dermatology specialty pharmaceutical company focused primarily on the development and marketing of its Levulan(R) Photodynamic Therapy (PDT ... -Genetic Engineering News

DUSA Pharmaceuticals Reports Second Quarter 2006 Corporate ...  Aug 8, 2006
Stiefel Laboratories, Inc., the Company's Latin American partner, is actively working towards a Brazilian launch of Levulan ® , scheduled for the first ... -CCNMatthews

Brooks: Painless Procedure Could Help Prevent Skin Cancer  Jul 20, 2006
...“And there's a lot of them up there.�. Cutty volunteered to have a medicine called levulan painted on his lesions, Brooks said. ... -Pittsburgh Channel.com

DUSA Pharmaceuticals Sues Additional Physicians and a Chemical ...  Jul 11, 2006
...property, to protect our loyal customers from unfair competition, and to protect patients by assuring that they are receiving genuine Levulan® in their PDT ... -Market Wire

Hitting Acne Where It Hurts; Successful Treatment Offered by Laser ...  Jul 18, 2006
The skin is prepped with a degreasing cleanser and a topical solution that has light-triggered action (called Levulan) is applied to any area that has acne ... -PR Web

DUSA Pharmaceuticals to Present at the Jefferies Life Sciences ...  Jun 22, 2006
...is an integrated dermatology specialty pharmaceutical company focused primarily on the development and marketing of its Levulan® Photodynamic Therapy (PDT ... -Market Wire

Dusa Pharmaceuticals Sues Additional Physicians for Infringement ...  Jul 11, 2006
...property, to protect our loyal customers from unfair competition, and to protect patients by assuring that they are receiving genuine Levulan in their PDT ... -ag-IP-news Agency



Dusa Pharmaceuticals Announces Court Ruling Halts Sale of Generic ...  May 15, 2006
...is an integrated dermatology specialty pharmaceutical company focused primarily on the development and marketing of its Levulan ® Photodynamic Therapy (PDT ... - CCNMatthews

CORRECTION: DUSA Pharmaceuticals Reports First Quarter 2006 ...  May 10, 2006
Levulan(R) Kerastick(R) unit sales for the quarter totaled 32,934, also a new high, compared to the 28,704 Kerastick units sold in the quarter ended March 31 ... - International News Service

CORRECTION: DUSA Pharmaceuticals Reports First Quarter 2006 ...  May 10, 2006
Levulan ® Kerastick ® unit sales for the quarter totaled 32,934, also a new high, compared to the 28,704 Kerastick units sold in the quarter ended March 31 ... - CCNMatthews

Adult acne  Apr 25, 2006
When the sensitizing solution Levulan is applied to the skin first, she says, "it bumps up the therapy of the blue light alone and gives a better result ... - Dailyrecord.com

Combating Skin Cancer: The Most Common Cancer  May 5, 2006
...use liquid nitrogen to treat pre-cancers (or AKs), she also treats them with a two-step process involving a topical solution called Levulan Kerastick coupled ... - eMaxHealth.com





DUSA Pharmaceuticals and New England Compounding Center Announce ...  Apr 10, 2006
...with NECC," stated Bob Doman, President of DUSA Pharmaceuticals, "We believe that this settlement supports the validity of our patents on Levulan ® (ALA) for ... - CCNMatthews

Cosmetics tips  Mar 29, 2006
I have a lot of actinic keratoses on my face, and my dermatologist has recommended Levulan and BLU-U light therapy (activated photo facials). ... - Fort Wayne News Sentinel

More adults battling the plague of pimples  Mar 27, 2006
When the sensitizing solution Levulan is applied to the skin first, she says, "it bumps up the therapy of the blue light alone and gives a better result ... - Arizona Republic

DUSA Pharmaceuticals Closes Acquisition of Sirius Laboratories  Mar 14, 2006
DUSA Pharmaceuticals, Inc.(R) (NASDAQ NMS:DUSA), developer and marketer of Levulan(R) photodynamic therapy (PDT) for the treatment of dermatologic conditions ... - Genetic Engineering News

DUSA Pharmaceuticals Closes Acquisition of Sirius Laboratories  Mar 14, 2006
WILMINGTON, Mass.--(BUSINESS WIRE)--Mar 14, 2006 - DUSA Pharmaceuticals, Inc.(R) (NASDAQ NMS:DUSA), developer and marketer of Levulan(R) photodynamic therapy ... - PharmaLive.com

DUSA Pharmaceuticals Reports Lawsuit  Apr 1, 2006
...is a biopharmaceutical company engaged primarily in the development of Levulan Photodynamic Therapy (PDT) and Photodetection (PD) for multiple medical ... - ag-IP-news Agency

Dusa buys Sirius Lab for $22 M  Mar 14, 2006
Both companies make dermatological products. Dusa markets Levulan photodynamic therapy to treat dermatological conditions. Sirius ... - United Press International

DUSA Pharmaceuticals, Inc.: American Academy of Dermatology ...  Mar 9, 2006
® (NASDAQ NMS:DUSA) reported today that DUSA's Levulan ® (aminolevulinic acid HCl, ALA) photodynamic therapy (PDT) was featured as one of 9 key topics ... - CCNMatthews

Acid, Light Used To Destroy Some Skin Cancers  Mar 9, 2006
The Levulan treatment starts with the application of an acid solution to the cancerous area. The acid is left to soak into the skin for about an hour. ... - INDYchannel.com

DUSA Pharmaceuticals, Inc.: American Academy of Dermatology ...  Mar 9, 2006
DUSA Pharmaceuticals, Inc.(R) (NASDAQ NMS:DUSA) reported today that DUSA's Levulan(R) (aminolevulinic acid HCl, ALA) photodynamic therapy (PDT) was featured as ... - Genetic Engineering News

DUSA Pharmaceuticals, Inc.: American Academy of Dermatology ...  Mar 9, 2006
WILMINGTON, Mass.--(BUSINESS WIRE)--March 9, 2006--DUSA Pharmaceuticals, Inc.(R) (NASDAQ NMS:DUSA) reported today that DUSA's Levulan(R) (aminolevulinic acid ... - Business Wire



DUSA Pharmaceuticals Reports Statistically Significant Results ...  Feb 24, 2006
The study used DUSA’s Levulan® (aminolevulinic acid HCl, ALA) Kerastick® incombination with either the Company’s BLU-U® brand blue light (“BLU-U ... - PharmaLive.com,

DUSA Pharmaceuticals Reports Fourth Quarter and Full Year 2005 ...  Feb 6, 2006
...to $2,545,000 and $7,988,000 respectively in the comparable 2004 periods, reflecting record Kerastick ® sales of the Company's Levulan ® photodynamic therapy ... - CCNMatthews,

Dusa Pharmaceuticals Reports Results from Phase II Clinical Trial ...  Feb 1, 2006
The results of the study indicate that both 'Levulan BLU-U' and 'BLU-U alone' appear to effectively reduce the number of both inflammatory and non-inflammatory ... - Business Wire,

Dusa shares plunge as acne drug study disappoints  Feb 1, 2006
The drug, Levulan, used in combination with Dusa's BLU-U (Blue Light Photodynamic Therapy Illuminator) appeared to be about as effective as BLU-U therapy alone ... - Reuters

Dusa Pharma Shares Plummet on Acne Study  Feb 1, 2006
The therapy is designed to be a two-step process that starts with Dusa's Levulan Kerastick solution to prime the skin, making affected areas more sensitive to ... - Houston Chronicle,

DUSA Pharmaceuticals Sues Additional Physicians For Infringement ...  Jan 23, 2006
In one of these cases, the defendant physician also admitted to illegally using DUSA's Levulan(R) trademark in connection with his infringing activities and ... - PharmaLive.com

DUSA Pharmaceuticals Reports Fourth Quarter and Full Year 2005 ...  Feb 6, 2006
...to $2,545,000 and $7,988,000 respectively in the comparable 2004 periods, reflecting record Kerastick(R) sales of the Company's Levulan(R) photodynamic therapy ... - Genetic Engineering News

DUSA Pharmaceuticals Reports Fourth Quarter and Full Year 2005 ...  Feb 6, 2006
...to $2,545,000 and $7,988,000 respectively in the comparable 2004 periods, reflecting record Kerastick ® sales of the Company's Levulan ® photodynamic therapy ... - CCNMatthews

Dusa Pharmaceuticals Reports Results from Phase II Clinical Trial ...  Feb 1, 2006
...(NASDAQ NMS:DUSA), today reported results from its multi-center Phase II clinical study of photodynamic therapy (PDT) using DUSA's Levulan(R) (aminolevulinic ... - Genetic Engineering News

Dusa Pharmaceuticals Reports Results from Phase II Clinical Trial ...  Feb 1, 2006
The results of the study indicate that both 'Levulan BLU-U' and 'BLU-U alone' appear to effectively reduce the number of both inflammatory and non-inflammatory ... - Business Wire

Dusa shares plunge as acne drug study disappoints  Feb 1, 2006
The drug, Levulan, used in combination with Dusa's BLU-U (Blue Light Photodynamic Therapy Illuminator) appeared to be about as effective as BLU-U therapy alone ... - Reuters

DUSA Pharmaceuticals Announces Exclusive Agreement With Stiefel ...  Jan 18, 2006
The agreement covers current and future uses of DUSA's proprietary Levulan(R) Kerastick(R) for photodynamic therapy (PDT) in dermatology. ... - Business Wire

DUSA Pharmaceuticals, Inc. to Host Fourth Quarter and Full Year ...  Feb 1, 2006
...is a biopharmaceutical company engaged primarily in the development and marketing of Levulan Photodynamic Therapy (PDT) and Photodetection (PD) for multiple ... - Genetic Engineering News

Dusa Pharma Shares Plummet on Acne Study  Feb 1, 2006
The therapy is designed to be a two-step process that starts with Dusa's Levulan Kerastick solution to prime the skin, making affected areas more sensitive to ... - Houston Chronicle

Doctors fear acne drug rules go too far  Jan 30, 2006
Another acne treatment, Levulan-PDT (for photodynamic therapy), involves using a laser or blue light after coating the face in a cream that makes the skin more ... - Atlanta Journal Constitution (subscription)

Advanced Facial Plastic Surgery Center in Dallas Offers ...  Jan 9, 2006
...(PRWEB) January 9, 2006 -- The Levulan PDT system is an advanced two-step treatment for minimally to moderately thick AKs. First ... - PR Web

Clinic offers beautification procedures  Jan 16, 2006
...and she performs PhotoFacial Rejuvenation for sun damaged skin and removal of brown spots and reddish blotches, PhotoDynamic Therapy with Levulan for treatment ... - Sarasota Herald-Tribune

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional